Heres what current science, and real-world patient experience, tells us
The skin of the scalp is thicker
Compared with long-acting insulin, GLP-1RA therapy reduces the risk of composite liver disease (cirrhosis or hepatocellular carcinoma) in patients with type 2 diabetes by 44%, with a 41% reduction in cirrhosis risk and a 53% reduction in hepatocellular carcinoma risk
We will work with you to determine the best course of action and devise a treatment plan that will take into account the severity of your symptoms, the size of your prostate, and your overall health
How can we think that manipulating our GLP or GIP production in such drastic ways would not have a downstream impact somewhere else
Patients considering this strategy should only do so under provider supervision, especially because some manufacturer pens are not designed for divided dosing